AAHS 2015: Exparel vs. Marcaine for postoperative analgesia in outpatient wrist procedures
Bupivicaine Extended-Release Liposome vs. Marcaine for Early Post-Operative Pain Control Following Wrist Operations: A Prospective Randomized Double-Blind Controlled Trial
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
28 patients were randomized to recieve either Exparel (bupivacaine extended-release liposome) or Marcaine (bupivacaine) following either carpometacarpal arthroplasty (CMCA) or proximal row carpectomy (PRC). The purpose of the study was to determine whether Exparel was effective in reducing pain, reducing opioid use and opioid side effects, and improving long-term hand function when compared to Mar...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE